Europe
Develops self-balancing exoskeletons and the Calvin-40 industrial humanoid for material-handling work.
Headquarters
Paris, FR
Data as of
Sep 2026
Disclosed funding
—
Est. valuation
Private company; no current valuation imported
Production targetPrepare production ramp for 12 announced customer organizations
Customers / pilots12 undisclosed customer organizations; Renault Group deployment plan announced separately
Customer commitments are company-stated; Calvin-40 remains classified as ANNOUNCED because completed customer deployments are not yet established.
Product dossier
Flagship productCalvin-40
The “brain”Self-balancing locomotion and Physical AI stack derived from medical exoskeleton deployments
Real-world traction
Wandercraft says Calvin-40 has secured 12 blue-chip customers across automotive, logistics, retail, healthcare and defense.
Latest signal · Sep 4, 2026
Wandercraft announced 12 customers for the Calvin-40 industrial humanoid and said it is preparing to ramp production while expanding manipulation capabilities.
wandercraft.eu ↗ProvenanceCompany-statedIndependentEstimate